NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 Begins
08/10/2020
The study is taking place in hospitalized adults in the United States, Mexico and 16 other countries.
The study is taking place in hospitalized adults in the United States, Mexico and 16 other countries.